Rachel L. Graham

机构：University of North Carolina at Chapel Hill, Ochsner Health System · ORCID：0000-0002-3143-6515

发表论文 154 篇 · 总被引 19794 次 · h-index 42

代表论文

• A live dengue virus vaccine carrying a chimeric envelope glycoprotein elicits dual DENV2-DENV4 serotype-specific immunity (2023 · Nature Communications · 被引 19)
• Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19 (2024 · Journal of Virology · 被引 15)
• An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivo (2024 · Cell Reports · 被引 12)
• 1- O -Octadecyl-2- O -benzyl- sn -glyceryl-3- phospho -GS-441524 (V2043). Evaluation of Oral V2043 in a Mouse Model of SARS-CoV-2 Infection and Synthesis and Antiviral Evaluation of Additional Phospholipid Esters with Enhanced Anti-SARS-CoV-2 Activity (2023 · Journal of Medicinal Chemistry · 被引 11)
• Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2025 · The Lancet Infectious Diseases · 被引 10)
• Mapping of susceptibility loci for Ebola virus pathogenesis in mice (2024 · Cell Reports · 被引 10)